Compass Diversified Holdings — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Compass Diversified Holdings filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $536.61M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $464.98M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $431.53M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $408.56M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $421.61M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $364.95M | Feb 24, 2022 |
| FY2021 | Jun 30, 2020 | $286.22M | Feb 24, 2022 |
| FY2021 | Mar 31, 2020 | $286.79M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $387.00M | Feb 24, 2021 |
| FY2020 | Sep 30, 2019 | $388.31M | Feb 24, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $468.56M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $472.56M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $478.69M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $453.78M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $493.93M | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $456.55M | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $426.71M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $410.83M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $451.30M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $427.06M | Dec 8, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $978.31M | Mar 2, 2017 |
| FY2016 | Dec 31, 2015 | $727.98M | Mar 2, 2017 |
| FY2016 | Dec 31, 2014 | $636.68M | Mar 2, 2017 |
| FY2015 | Dec 31, 2013 | $740.71M | Feb 29, 2016 |
| FY2012 | Dec 31, 2012 | $884.72M | Mar 6, 2013 |
| FY2012 | Dec 31, 2011 | $606.64M | Mar 6, 2013 |
| FY2012 | Dec 31, 2010 | $504.66M | Mar 6, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $202.10M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $207.72M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $208.54M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $196.03M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $190.65M | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $196.63M | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $188.19M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $174.95M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $178.56M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $168.06M | Dec 8, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($71.19M) | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | ($74.02M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | ($51.22M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | ($29.99M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($43.60M) | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | ($36.03M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | ($73.05M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | ($56.18M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $98.03M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | ($54.66M) | Dec 8, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.97M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | ($11.07M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | ($27.24M) | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $3.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($18.56M) | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $8.32M | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $7.48M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | ($12.11M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($57.97M) | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | ($24.93M) | Dec 8, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $16.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $13.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $11.70M | Dec 8, 2025 |
| FY2023 | Dec 31, 2021 | $11.40M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $3.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $800.0K | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.20M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.40M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $1.70M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $660.67M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $587.52M | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $145.96M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $137.58M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $137.72M | Dec 8, 2025 |
| FY2025 | Dec 31, 2023 | $502.01M | Feb 27, 2026 |
| FY2024 | Sep 30, 2023 | $121.19M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $121.47M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $118.53M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $441.63M | Dec 8, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.83M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($151.09M) | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | ($134.98M) | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | ($86.63M) | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | ($25.37M) | Dec 8, 2025 |
| FY2025 | Dec 31, 2023 | $16.64M | Feb 27, 2026 |
| FY2024 | Sep 30, 2023 | $13.02M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $14.21M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $974.0K | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | ($46.65M) | Dec 8, 2025 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.32M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $56.70M | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $33.84M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $18.71M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $7.73M | Dec 8, 2025 |
| FY2025 | Dec 31, 2023 | $55.02M | Feb 27, 2026 |
| FY2024 | Sep 30, 2023 | $38.16M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $28.33M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $14.87M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $60.18M | Dec 8, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.04B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.30B | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $3.27B | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $3.23B | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $3.29B | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | $3.33B | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $3.35B | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $3.38B | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $3.38B | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $3.49B | Dec 8, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.47B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.77B | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $2.71B | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $2.61B | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $2.55B | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | $2.47B | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $2.56B | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $2.48B | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $2.41B | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $2.56B | Dec 8, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $442.02M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $678.62M | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $672.22M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $711.34M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $799.72M | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | $929.66M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $782.12M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $863.72M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $930.39M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $877.58M | Dec 8, 2025 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $895.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $895.92M | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $876.05M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $875.65M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $895.17M | Dec 8, 2025 |
| FY2025 | Dec 31, 2023 | $773.57M | Feb 27, 2026 |
| FY2024 | Sep 30, 2023 | $830.40M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $862.97M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $863.77M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $863.77M | Dec 8, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.31B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($1.00B) | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | ($935.50M) | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | ($874.21M) | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | ($776.21M) | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | ($646.23M) | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | ($720.25M) | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | ($641.58M) | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | ($576.16M) | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | ($632.25M) | Dec 8, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.02M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $59.66M | Feb 27, 2026 |
| FY2024 | Sep 30, 2024 | $64.94M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | $61.46M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | $59.51M | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | $446.62M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | $56.79M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | $58.85M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | $45.88M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $52.68M | Dec 8, 2025 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.67B | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | $1.83B | Dec 8, 2025 |
| FY2022 | Dec 31, 2021 | $1.28B | Mar 1, 2023 |
| FY2020 | Dec 31, 2020 | $899.46M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $394.45M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.10B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $590.03M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $557.34M | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (3) | Dec 8, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | (1) | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | (1) | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | (1) | Dec 8, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Dec 8, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | (1) | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | (1) | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 8, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75.24M | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | 75.24M | Dec 8, 2025 |
| FY2024 | Sep 30, 2024 | 75.65M | Dec 8, 2025 |
| FY2024 | Jun 30, 2024 | 75.48M | Dec 8, 2025 |
| FY2024 | Mar 31, 2024 | 75.23M | Dec 8, 2025 |
| FY2024 | Dec 31, 2023 | 75.27M | Dec 8, 2025 |
| FY2024 | Sep 30, 2023 | 71.82M | Dec 8, 2025 |
| FY2024 | Jun 30, 2023 | 71.90M | Dec 8, 2025 |
| FY2024 | Mar 31, 2023 | 71.99M | Dec 8, 2025 |
| FY2024 | Dec 31, 2022 | 72.20M | Dec 8, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $69.55M | Mar 6, 2013 |
| FY2011 | Dec 31, 2011 | $66.92M | Mar 7, 2012 |
| FY2011 | Dec 31, 2010 | $55.17M | Mar 7, 2012 |
| FY2011 | Dec 31, 2009 | $46.34M | Mar 7, 2012 |